Table 2.
N (%) | |
---|---|
Breast surgery | |
Quadrantectomy | 8 (17.8) |
Mastectomy | 37 (82.2) |
Axillary lymph‐node surgery | |
Sentinel lymph‐node dissection | 2 (4.4) |
Axillary lymph‐node dissection | 43 (95.6) |
Residual tumour size (cm) | |
In situ | 11 (24.4) |
Microinvasion‐1.0 | 6 (13.4) |
1.1‐2 | 3 (6.6) |
2.1‐5 | 6 (13.4) |
No residual tumour | 19 (42.2) |
Number of positive lymph nodes | |
0 | 38 (84.4) |
1–3 | 4 (8.9) |
4–9 | 3 (6.7) |
The DECT trial.